The GBS│CIDP Foundation International is thrilled to announce the appointment of Dr. Luis Querol, MD, PhD, as its new Vice Chairman of its Global Medical Advisory Board (GMAB) and the Chairman of the Center of Excellence (COE) committee.
Dr. Querol brings a wealth of expertise to these leadership roles as an internationally recognized neurologist, Associate Professor at the Universitat Autònoma de Barcelona, and the Coordinator/Principal Investigator for the Autoimmune Neurology Program at Sant Pau Hospital in Barcelona, Spain. His groundbreaking work in identifying key biomarkers and autoantibodies has deeply advanced the global diagnosis and treatment standards for chronic autoimmune neuropathies.
A Message of Gratitude and Vision
“We are so incredibly grateful to Dr. Luis A. Querol Gutiérrez, MD, PhD,Coordinator of the Autoimmune Neurology Program at Sant Pau Hospital, and his Barcelona-based team for leading groundbreaking peripheral nerve research in Spain. Dr. Querol’s vital discovery of key biomarkers has truly transformed the diagnosis and classification of CIDP and autoimmune neuropathies. We are looking forward to his visionary leadership as Vice Chairman of the Global Medical Advisory Board (GMAB) and leading the global Center of Excellence (COE) committee as its Chairman—a monumental win for our global patient community!”
— Lisa Butler, CEO & President, GBS│CIDP Foundation International
Advancing Patient Care and Research
Reflecting on the ongoing collaboration between him and the Foundation, Dr. Querol emphasized the vital role the foundation plays, both globally and locally, for patients navigating rare, and often-neglected diseases and conditions:
“The GBS|CIDP Foundation International is a crucial organization for our patients. They have been instrumental in funding our fantastic early-career scientists that have made important discoveries in a field that is lacking basic biologists and dedicated clinician-scientists. The Foundation has helped us better understand the pathogenicity of autoantibodies in chronic autoimmune neuropathies, the role of blood and digital biomarkers for precision monitoring in GBS and CIDP and has funded groundbreaking research on the changes that peripheral nerves undergo when inflamed. When reflecting on a recent visit to his facilities in Barcelona, Dr. Querol further shared, “I was honored for the opportunity to show Foundation leadership directly the tangible effect their support has had on our junior researchers, which shape the future of the field.”
Please join us in celebrating Dr. Querol’s new appointments as we continue our shared mission to improve the lives of individuals affected by GBS, CIDP, MMN, and related conditions worldwide.
To learn more about our Centers of Excellence and/or find one near you, visit: https://www.gbs-cidp.org/centers-of-excellence/
To learn about the Foundation and the research we support, visit: https://www.gbs-cidp.org/research/
GBS|CIDP Foundation International GMAB and COE Staff Contact: Lori Baesiege, Patient Services Manager, lori.basiege@gbs-cidp.org
Other Articles You May Like
New Research Offers Insight Into How Autoimmune Disorders May Develop
A newly published scientific paper explores how autoimmune disorders may arise, using Guillain-Barré syndrome (GBS)…
The XPERT study
The XPERT Study is testing whether a subcutaneous immunoglobulin (SCIG) can provide similar blood levels…
Shape The Future of CIDP Research
Study Title The Chronic Inflammatory Demyelinating Polyneuropathy-Health Index (CIDP-HI): Development of a Patient-Reported Outcome Measure…